Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Management of Idiopathic Interstitial Pneumonia Treated only with Traditional Korean Medicine: a Case Report

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2014, v.35 no.4, pp.104-109








  • Downloaded
  • Viewed

Abstract

Objectives: To present the case of a 76-year-old man diagnosed with idiopathic interstitial pneumonias (IIPs) treated exclusively with traditional Korean medicine (TKM). Methods: The patient was treated with the revised Sasammaekmundong-tang (rSMT), acupuncture, and pharmacopuncture from September 2013 to May 2014 in our outpatient clinic. We prescribed rSMT three times a day for 4 months. Acupuncture and pharmacopuncture were performed twice a week for 9 months. To evaluate therapeutic efficacy, we recorded the patient’s chief complaints at each visit, and pulmonary function test was performed at intervals of three months. Chest radiography and chest computed tomography were performed before and after treatment, respectively. Results: During the course of the treatment, dyspnea, cough, sputum, and overall pulmonary function improved. Conclusions: We suggest that traditional Korean medicine (TKM) for IIPs patients might be effective in the control of the main symptoms of IIPs and in the recovery of respiratory function.

keywords
idiopathic interstitial pneumonias (IIPs), idopathic pulmonary fibrosis (IPF), traditional Korean medicine (TKM), revised Sasammaekmundong-tang


Reference

1

1. Kim DS. Idiopathic interstitial pneumonia. In: Respiratory Diseases. Seoul:Koonja publishing. 2004:457-68.

2

2. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733-48.

3

3. Kim DS. Diagnostic approaches to diffuse interstitial lung diseases. J Korean Med Assoc. 2009;52(1):5-13.

4

4. Katzenstein, AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998;157(4):1301-15.

5

5. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 1994;18:136-47.

6

6. Park IN, Jegal Y, Kim DS, Do KH, Yoo B, Shim TS, et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J. 2009;33:68-76.

7

7. Korean Medicine College Respiratory faculty. Respiratory Medicine. Seoul:Nado publishing. 2011:570-86.

8

8. Lee JS, Jung HJ, Jung SK, Rhee HG. the effects of Lonicerae Flos on bleomycin-induced lung fibrosis. J Korean Orient Int Med. 2004;25(1):71-80.

9

9. Rhu HC, Rhee HG, Jung SK, Jung HJ. The effect of Rehmanniae Radix on bleomycin-induced Lung Fibrosis. J Korean Orient Int Med. 2004;25(2):298-306.

10

10. Lee BS, Rhee HK, Jung SK, Jung HJ. The inhibitory effects of Liriopis tuber on the bleomycin-induced lung fibrosis in C75BL/6J mice. J Korean Orient Int Med. 2004;25(4):93-104.

11

11. Lee KS, Rhee HK, Jung SK, Jung HJ. The effects of Fritillariae Rhizoma on bleomycin-induced lung Fiborsis. J Korean Orient Int Med. 2005;26(1):169-81.

12

12. Kim HJ, Lee HJ, Park EJ. The effects of Peucedani Radix on the bleomycin-induced lung fibrosis. J Korean Orient Ped. 2008;22(2):37-49.

13

13. Lee HJ. The effects of Okwada on the lung fibrosis mouse model. J Korean Orient Ped. 2009;23(3):233-40.

14

14. Lee HJ, Shin GS, Ahn JS. The preliminary study for therapeutic mechanism of Gamibojungikgi-tang and Gamijwagwi-eum for pulmonary fibrosis. J Korean Orient Ped. 2010;24(1):126-133.

15

15. Son JY, Yi CG, Park MY, Choi HY, Kim JD. A Clinical case report of diffuse interstitial lung disease. J East-west med. 2008;33(4):47-54.

16

16. Scientific Committee of the Korean Academy of Tuberculosis and Respiratory Diseases. 2008 national survey of idiopathic interstitial pneumonia in Korea. Tuberc Respir Dis. 2009;66(2):141-151.

17

17. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994;150:967-972.

18

18. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;157:199-203.

19

19. Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168:538-542.

20

20. Flaherty KR, Mumford JA, Murray S, Kazerooni EA, Gross BH, Colby TV, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003;168:543-548.

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine